Patent ID: 8969000
Filing Date: 2015-03-03
Classification: C12Q

Abstract:
1. A method for typing a sample of a human individual suffering from stage I or stage II non-small cell lung cancer (NSCLC) as indicating a low risk or high risk of recurrence of NSCLC within three years from identification of said NSCLC in said individual, the method comprising a) providing a lung tissue sample from said individual comprising non-small cell lung cancer cells or suspected to comprise non-small cell lung cancer cells; b) preparing RNA from said tissue sample; c) determining RNA levels for a set of genes in said RNA; and d typing said sample as indicating a low risk or high risk of recurrence of NSCLC within three years from identification of said NSCLC in said individual on the basis of the levels of RNA determined for said set of genes, wherein said set of genes comprises at least two of the genes indicated by SEQ ID NOS. 1-216 and 218-237 in Table 3.